ChengDa Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 301201?
Owner Type	Number of Shares	Ownership Percentage
Institutions	186,442	0.123%
Employee Share Scheme	1,452,744	0.959%
VC/PE Firms	17,391,840	11.5%
Private Companies	20,462,280	13.5%
General Public	50,416,458	33.3%
Individual Insiders	61,559,360	40.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 23 shareholders own 66.72% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
27.8%	Jianli Ge	42,031,360	CN¥869.6m	0%	no data
12.9%	Honglin Huang	19,528,000	CN¥404.0m	0%	no data
11.5%	Sheng Tai Investment & Management Co., Ltd.	17,391,840	CN¥359.8m	0%	100.0%
2.89%	Jiaxing Mai'erte Equity Investment Partnership Enterprise (Limited Partnership)	4,378,947	CN¥90.6m	0%	no data
2.89%	Shanghai Shengweige Enterprise Management Partnership Enterprise (Limited Partnership)	4,378,947	CN¥90.6m	0%	no data
2.2%	Jiashan Huicheng Equity Investment Partnership Enterprise (Limited Partnership)	3,328,640	CN¥68.9m	0%	no data
2.11%	Shenzhen Jiuheng Investment Consulting Co., Ltd.	3,200,000	CN¥66.2m	0%	no data
1.74%	Jiashan Hecheng Equity Investment Partnership (Limited Partnership)	2,632,000	CN¥54.5m	0%	no data
0.99%	Shanghai Fujiurong Enterprise Management Center (Limited Partnership)	1,495,886	CN¥30.9m	0%	no data
0.96%	ChengDa Pharmaceuticals Co., Ltd., ESOP	1,452,744	CN¥30.1m	0%	no data
0.69%	Jiashan Huida Investment Partnership Enterprise (Limited Partnership)	1,047,860	CN¥21.7m	0%	no data
0.075%	China Southern Asset Management Co., Ltd.	114,300	CN¥2.4m	0%	no data
0.034%	Zhong Ou Fund Management Co., Ltd	51,600	CN¥1.1m	0%	no data
0.005%	China Universal Asset Management Company Ltd.	7,605	CN¥157.3k	0%	no data
0.0037%	Manulife Asset Management	5,589	CN¥115.6k	0%	no data
0.0019%	E Fund Management Co., Ltd.	2,800	CN¥58.0k	0%	no data
0.0012%	GF Fund Management Co., Ltd.	1,865	CN¥38.5k	0%	no data
0.00061%	Harvest Fund Management Co. Ltd.	921	CN¥19.1k	0%	no data
0.00053%	Beixin Ruifeng Fund Management Co., Ltd.	798	CN¥16.6k	0%	no data
0.0003%	Guotai Asset Management Company Limited	450	CN¥9.4k	0%	no data
0.0002%	Essence Fund Management Co., Ltd	299	CN¥6.3k	0%	no data
0.00013%	Galaxy Asset Management Co. Ltd.	196	CN¥4.1k	0%	no data
0.00001%	New China Fund Management Co., Ltd.	19	CN¥313.4	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 16:28
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ChengDa Pharmaceuticals Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution